Clinical Trials in Pittsburgh

Showing 5401-5420 of 21,047 trials

Registry of Arthrex Hand and Wrist Products

NCT05046600

A Multi-Center, Prospective Registry to Evaluate the Continued Safety and Effectiveness of Hand and Wrist Products

Ulnar/Radial Collateral Ligament ReconstructionLigament Repair or ReconstructionSmall Bone Fragments and Arthrodesis+7 more

Arthrex, Inc.650 participantsStarted Jul 2021

Phoenix, Arizona, United States • Tuscon, Arizona, United States • Iowa City, Iowa, United States +2 more locations

Active Not RecruitingPhase 3155 miles

Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)

NCT02612454

The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD. The secondary objectives of the study are: * To assess the long-term efficacy of dupilumab in pediatric participants with AD * To assess the trough concentrations of functional dupilumab in serum and the immunogenicity in pediatric participants with AD after re-treatment with dupilumab Optional Pre-filled Pen (PFP) Sub-Study in pediatric patients ≥2 to \<12 years of age with AD Co-Primary Objectives are: * To evaluate the pharmacokinetic (PK) of dupilumab PFPs * To evaluate the safety of dupilumab PFPs Secondary Objective is: \- To evaluate the immunogenicity of dupilumab PFPs

Atopic Dermatitis

Regeneron Pharmaceuticals880 participantsStarted Oct 2015

Birmingham, Alabama, United States • Gilbert, Arizona, United States • Bakersfield, California, United States +81 more locations

Registry of Arthrex Hand and Wrist Products

Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)

Find Trials by Condition in Pittsburgh

The Biomarkers in the Hyperbaric Oxygen Brain Injury Treatment Trial (BioHOBIT)

Open Label Extension for 43USSA1812

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite

1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation

Adolescent Master Protocol

BIG Study (Brain, Immune, and Gut Health Evaluation of Infants/Young Children Fed Infant Formula, and Later Supplemental Toddler Nutrition, With 5 Specific HMOs)

Cough Reduction in IPF With Nalbuphine ER

Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD

Effect of Ketamine and Etomidate During RSI on Long Term Outcomes

A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures

Gluten Technology and Education for Celiac Health

Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas

FS120 Phase 1/1b Study in Patients With Advanced Malignancies

A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients

A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy

Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics